JP2004535178A - 新規変異 - Google Patents

新規変異 Download PDF

Info

Publication number
JP2004535178A
JP2004535178A JP2002587594A JP2002587594A JP2004535178A JP 2004535178 A JP2004535178 A JP 2004535178A JP 2002587594 A JP2002587594 A JP 2002587594A JP 2002587594 A JP2002587594 A JP 2002587594A JP 2004535178 A JP2004535178 A JP 2004535178A
Authority
JP
Japan
Prior art keywords
sodium channel
polypeptide
epilepsy
mutation event
subunit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2002587594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004535178A5 (cg-RX-API-DMAC7.html
Inventor
ジョン, チャールズ マレイ,
ロビン, ヘザー ワレス,
アイリーン, シェッファー イングリッド,
Original Assignee
バイオノミックス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオノミックス リミテッド filed Critical バイオノミックス リミテッド
Publication of JP2004535178A publication Critical patent/JP2004535178A/ja
Publication of JP2004535178A5 publication Critical patent/JP2004535178A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2002587594A 2001-05-10 2002-05-09 新規変異 Abandoned JP2004535178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR4922A AUPR492201A0 (en) 2001-05-10 2001-05-10 Novel mutation
PCT/AU2002/000581 WO2002090532A1 (en) 2001-05-10 2002-05-09 Novel mutation

Publications (2)

Publication Number Publication Date
JP2004535178A true JP2004535178A (ja) 2004-11-25
JP2004535178A5 JP2004535178A5 (cg-RX-API-DMAC7.html) 2005-08-18

Family

ID=3828909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002587594A Abandoned JP2004535178A (ja) 2001-05-10 2002-05-09 新規変異

Country Status (6)

Country Link
US (1) US20040191791A1 (cg-RX-API-DMAC7.html)
EP (1) EP1385945A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004535178A (cg-RX-API-DMAC7.html)
AU (1) AUPR492201A0 (cg-RX-API-DMAC7.html)
CA (1) CA2446838A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002090532A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1407013B1 (en) 2001-07-18 2007-09-12 Bionomics Limited Mutations in ion channels
WO2008079412A2 (en) * 2006-12-22 2008-07-03 The Trustees Of Columbia University In The City Of New York Methods and compositions to treat arrhythmias
CN117821509A (zh) 2017-04-03 2024-04-05 编码治疗公司 组织选择性转基因表达
CN118345115A (zh) 2017-12-01 2024-07-16 编码治疗公司 工程化的dna结合蛋白
SG11202113048SA (en) 2019-05-29 2021-12-30 Encoded Therapeutics Inc Compositions and methods for selective gene regulation
WO2024038160A1 (en) * 2022-08-18 2024-02-22 Vib Vzw Means and methods to modulate neuron excitability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171589A1 (en) * 1999-04-15 2002-01-16 Cambridge University Technical Services Limited A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
AU1846501A (en) * 1999-11-26 2001-06-04 Bionomics Limited Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy

Also Published As

Publication number Publication date
EP1385945A1 (en) 2004-02-04
AUPR492201A0 (en) 2001-06-07
EP1385945A4 (en) 2004-12-22
WO2002090532A1 (en) 2002-11-14
US20040191791A1 (en) 2004-09-30
CA2446838A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
US8288096B2 (en) Diagnostic method for epilepsy
JP4204317B2 (ja) 熱性痙攣プラスを伴う全般てんかんのニューロン遺伝子のナトリウムチャネルα1サブユニットおよびそのポリペプチドの変異およびその治療
US7157569B2 (en) Mutation associated with epilepsy
AU2002318972B8 (en) Mutations in ion channels
US20040191791A1 (en) Novel mutation
US20050032155A1 (en) Mutation in the beta2 nicotinic acetycholine receptor subunit associated with nocturnal frontal lobe epilepsy
WO2005024024A1 (en) Mutations in the nedd4 gene family in epilepsy and other cns disorders
AU2002216826B2 (en) Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
AU2001265698B2 (en) Mutation associated with epilepsy
AU2002252833A1 (en) Novel mutation
AU2004200978A1 (en) A diagnostic method for epilepsy
NZ550702A (en) Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
AU2001265698A1 (en) Mutation associated with epilepsy
WO2004053128A1 (en) Mutations in gaba-b receptor 1 associated with epilepsy
AU2001256003A1 (en) Mutation in the beta2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050406

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20050921

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050921